U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
  1. Vaccines

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted

STN#: 125419
Proper Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
Tradename: N/A
Manufacturer: ID Biomedical Corporation of Quebec

Indication

  • For active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine. Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is approved for use in persons (6 months and older) at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine.

Product Information

Supporting Documents

Related Information

Back to Top